氨酚羟考酮依赖性及滥用风险分析

中国药物警戒 ›› 2012, Vol. 9 ›› Issue (8): 476-478.

氨酚羟考酮依赖性及滥用风险分析

马军丽, 逄立艳, 周立新, 张黎明

北京市药品不良反应监测中心,北京100024

收稿日期:2011-10-31 出版日期:2012-08-10 发布日期:2015-08-07
作者简介:马军丽,女,硕士,药物滥用监测。

Oxycodone and Acetaminophen Dependence and Abuse Risk Analysis

MA Jun-li, PANG Li-yan, ZHOU Li-xin, ZHANG Li-ming

Beijing Center For ADR Monitoring, Beijing 100024, China

Received:2011-10-31 Online:2012-08-10 Published:2015-08-07

摘要/Abstract

摘要： 盐酸羟考酮是盐酸吗啡的衍生物,药理作用与吗啡相似,已有动物实验表明羟考酮与吗啡的强化效应相似,具有相同的精神依赖性潜力。在美国和澳大利亚等国,羟考酮类产品是最常被遭到转移和滥用的药品之一。虽然盐酸羟考酮的单方和复方制剂都有可能引发滥用,但在我国盐酸羟考酮的复方制剂即氨酚羟考酮是按照处方药管理,相对于按照麻醉药品管理的单方制剂流失和滥用的可能性更大。医疗机构和药品监管部门应当加强对氨酚羟考酮的管理和监测,积极避免流失和滥用的发生。

关键词: 氨酚羟考酮, 依赖性, 滥用风险

Abstract: Oxycodone hydrochloride is a derivative of morphine. The pharmacological effects of the oxycodone hydrochloride is similar to morphine. There has been animal experiments show that oxycodone and morphine are similar in strengthening effect, and they have the same potential for psychological dependence. In the United States and Australia, oxycodone products are one of the most common drugs being diverted and abused. Although the single and compound preparations of oxycodone hydrochloride are both likely to cause abuse, In China, oxycodone acetaminophen(oxycodone hydrochloride compound) is managed in accordance with prescription drug, so it is more likely to be lossed and abused compared to the single preparation of oxycodone hydrochloride which is managed in accordance with narcotic drugs. Medical institutions and drug regulatory departments shall strengthen the management and monitoring of oxycodone acetaminophen to prevent loss and abuse.

Key words: oxycodone acetaminophen, dependence, abuse risk

马军丽, 逄立艳, 周立新, 张黎明. 氨酚羟考酮依赖性及滥用风险分析[J]. 中国药物警戒, 2012, 9(8): 476-478.

MA Jun-li, PANG Li-yan, ZHOU Li-xin, ZHANG Li-ming. Oxycodone and Acetaminophen Dependence and Abuse Risk Analysis[J]. Chinese Journal of Pharmacovigilance, 2012, 9(8): 476-478.

参考文献

[1] 徐国柱,刘丽京,朱天岳,等. 泰勒宁胶囊用于镇痛的临床评价[J].中国新药杂志,2001,10（10）:768-771.
[2] 张象麟主编. 药物临床信息参考[M].重庆:重庆出版社,2008:1377.
[3] 陈新谦,金有豫,汤光. 新编药物学[M].北京：人民卫生出版社,2003:184.
[4] 希恩·C·斯威曼主编. 马丁代尔药物大典（原著第35版）[M].北京：化学工业出版社,2009:83.
[5] 阴元魁,高永良,李明亚.羟考酮的研究进展[J].中国医院药学杂志,2008,28（1）:57-59.
[6] 哈鹰,王卫平.用大鼠静脉自身给药方法评价盐酸羟考酮的精神依赖性潜力[J].中国药物依赖性杂志,2004,13（2）:109-111.
[7] Mierzewski P,Koros E,Goldberg S R,et a1. Intravenous self-administration of morphine and cocaine：a comparative study[J]．Pol J Pharmacol,2003,55:713-26.
[8] Beardsley P M,Aceto M D,Cook C D,et a1．Discriminative stimulus,reinforcing,physical dependence,and antinociceptive efects of oxycodone in mice,rats and the-SUS monkeys[J]. Exp Clin Psychopharmaco1,2004,12（l）:63-72.
[9] 刘锐克,孙桂宽,穆悦,等.可待因及羟考酮、右丙氧芬复方制剂依赖性的流行病学调查[J].中国药物依赖性杂志,2004,13（3）:213-217.
[10] 泰勒宁( 氨酚羟考酮胶囊) 简要讲义[J]. 中国药物滥用防治杂志,2007,13（6）:369-370.
[11] 2010年国际麻醉品管制局报告（中译本）[M].国际麻醉品管制局,纽约,2011:55,93.
[12] 2009年国际麻醉品管制局报告（中译本）[M].国际麻醉品管制局,纽约,2010:13.
[13] NIDA. Prescription Drug Abuse[EB/OL].[2008-3]. http://www.drugabuse.gov.
[14] FDA. Safety Information : OxyContin (oxycodone HCl)[EB/OL].[2001-7-25]http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172565.htm.
[15] DAWN. Highlights of the 2009 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits[EB/OL].[2010-12-28].http://store.samhsa.gov/product/Highlights-
of-the-2009-Drug-Abuse-Warning- Network-DAWN-Findings-
16 on-Drug-Related-Emergency-Department-Visits/DAWN10-1228.
[16] 孙凌.氨酚羟考酮片致幻觉等严重不良反应一例[J]. Chin J Conv-
alescent Med,2010,19（11）:1046.
[17] 国家食品药品监督管理局.关于公布麻醉药品和精神药品品种目录（2007年版）的通知[Z].2007-10-11.
[18] 国家食品药品监督管理局.关于含麻醉药品复方制剂管理的通知[Z].2004-3-19.
[19] 国家食品药品监督管理局.数据查询[DB/OL].http：//www.sda.gov.
cn/WS01/CL0001/.
[20] 蔡芸,闫丽莎,魏宇宁,等.我院复方镇痛药氨酚羟考酮的临床应用分析[J]. Chinese Journal of New Drugs,2009,18（9）:862-864.